Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Blocking mTORC1 reduces skin tumor growth in mice.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

ILK is essential for skin development, pigmentation, and healing.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

Laminin-511 is essential for proper melanocyte movement and development in mice.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Montelukast is linked to increased risks of suicidal thoughts and depression.

KGF-1 135 is a stable and effective alternative for treating oral mucositis.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Lack of functional CYLD in mice leads to early aging and cancer.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.